Dr. Martin Murphy is a member of the National Cancer Policy Forum of the National Academy of Medicine of the National Academy of Sciences; Director Emeritus of the Foundation for the National Institutes of Health (FNIH). He is a Fellow of the American Society of Clinical Oncology (ASCO), and founding Executive Editor of three peer-reviewed biomedical journals: The Oncologist, Stem Cells and Stem Cells Translational Medicine.
A co-founder of the Society for Translational Oncology; a member of the Scientific Advisory Board of Hatteras Venture Partners; a charter member of the International Advisory Board of the VU University Medical Imaging Center; a charter member of Queen's University Belfast School of Medicine International Review Board; Dr. Murphy is also Chairman Emeritus of the Conquer Cancer Foundation of ASCO; convener of ACT-China; and a steering committee member and senior consultant to the Chinese Society of Clinical Oncology (CSCO).
As the Founding CEO of the non-profit CEO Roundtable on Cancer, Dr. Murphy continues to contribute to the vital work that was begun at the request of the 41st President, George H.W. Bush. He remains on the Board of Directors and serves as the Chief Executive Officer of the CEO Roundtable on Cancer – China. Likewise, as the Founding CEO of Project Data Sphere, LLC, a non-profit enterprise devoted to cancer clinical trial data-transparency, data-sharing and data-analysis founded by the CEO Roundtable on Cancer, Dr. Murphy remains active on its Board of Directors.